233 related articles for article (PubMed ID: 29872147)
1. Body mass index (BMI) trajectories and risk of colorectal cancer in the PLCO cohort.
Zheng R; Du M; Zhang B; Xin J; Chu H; Ni M; Zhang Z; Gu D; Wang M
Br J Cancer; 2018 Jul; 119(1):130-132. PubMed ID: 29872147
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Body Mass Index in Early and Middle Adulthood and Estimated Risk of Gastrointestinal Cancer.
Loomans-Kropp HA; Umar A
JAMA Netw Open; 2023 May; 6(5):e2310002. PubMed ID: 37163267
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Body Mass Index and Mortality in Patients With Colorectal Cancer Using Causal Diagrams.
Kroenke CH; Neugebauer R; Meyerhardt J; Prado CM; Weltzien E; Kwan ML; Xiao J; Caan BJ
JAMA Oncol; 2016 Sep; 2(9):1137-45. PubMed ID: 27196302
[TBL] [Abstract][Full Text] [Related]
4. Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies.
Petrick JL; Kelly SP; Liao LM; Freedman ND; Graubard BI; Cook MB
Br J Cancer; 2017 Mar; 116(7):951-959. PubMed ID: 28196067
[TBL] [Abstract][Full Text] [Related]
5. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
6. Lifetime Body Weight Trajectories and Risk of Renal Cell Cancer: A Large U.S. Prospective Cohort Study.
Deng Z; Hajihosseini M; Moore JX; Khan S; Graff RE; Bondy ML; Chung BI; Langston ME
Cancer Epidemiol Biomarkers Prev; 2023 Nov; 32(11):1651-1659. PubMed ID: 37624040
[TBL] [Abstract][Full Text] [Related]
7. Prediagnostic Body Mass Index Trajectories in Relation to Prostate Cancer Incidence and Mortality in the PLCO Cancer Screening Trial.
Kelly SP; Graubard BI; Andreotti G; Younes N; Cleary SD; Cook MB
J Natl Cancer Inst; 2017 Mar; 109(3):. PubMed ID: 27754927
[TBL] [Abstract][Full Text] [Related]
8. Body mass index and risk of second obesity-associated cancers after colorectal cancer: a pooled analysis of prospective cohort studies.
Gibson TM; Park Y; Robien K; Shiels MS; Black A; Sampson JN; Purdue MP; Freeman LE; Andreotti G; Weinstein SJ; Albanes D; Fraumeni JF; Curtis RE; Berrington de Gonzalez A; Morton LM
J Clin Oncol; 2014 Dec; 32(35):4004-11. PubMed ID: 25267739
[TBL] [Abstract][Full Text] [Related]
9. Clinical stages of colorectal cancer diagnosed in obese and overweight individuals in the Polish Colonoscopy Screening Program.
Spychalski P; Kobiela J; Wieszczy P; Kamiński MF; Reguła J
United European Gastroenterol J; 2019 Jul; 7(6):790-797. PubMed ID: 31316783
[TBL] [Abstract][Full Text] [Related]
10. Association of Aspirin Use With Mortality Risk Among Older Adult Participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Loomans-Kropp HA; Pinsky P; Cao Y; Chan AT; Umar A
JAMA Netw Open; 2019 Dec; 2(12):e1916729. PubMed ID: 31800071
[TBL] [Abstract][Full Text] [Related]
11. Prediagnosis body mass index and waist-hip circumference ratio in association with colorectal cancer survival.
Wang N; Khankari NK; Cai H; Li HL; Yang G; Gao YT; Xiang YB; Shu XO; Zheng W
Int J Cancer; 2017 Jan; 140(2):292-301. PubMed ID: 27706816
[TBL] [Abstract][Full Text] [Related]
12. Association of Obesity With Risk of Early-Onset Colorectal Cancer Among Women.
Liu PH; Wu K; Ng K; Zauber AG; Nguyen LH; Song M; He X; Fuchs CS; Ogino S; Willett WC; Chan AT; Giovannucci EL; Cao Y
JAMA Oncol; 2019 Jan; 5(1):37-44. PubMed ID: 30326010
[TBL] [Abstract][Full Text] [Related]
13. [Pre- and post-diagnosis body mass index in association with colorectal cancer death in a prospective cohort study].
Li HL; Fang J; Wu CX; Gao LF; Tan YT; Gu K; Shi Y; Xiang YB
Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):657-665. PubMed ID: 37580270
[No Abstract] [Full Text] [Related]
14. BMI trajectories and risk of overall and grade-specific prostate cancer: An observational cohort study among men seen for prostatic conditions.
Wang K; Chen X; Gerke TA; Bird VY; Ghayee HK; Prosperi M
Cancer Med; 2018 Oct; 7(10):5272-5280. PubMed ID: 30207080
[TBL] [Abstract][Full Text] [Related]
15. Excess body weight and colorectal cancer survival: the multiethnic cohort.
Maskarinec G; Harmon BE; Little MA; Ollberding NJ; Kolonel LN; Henderson BE; Le Marchand L; Wilkens LR
Cancer Causes Control; 2015 Dec; 26(12):1709-18. PubMed ID: 26358830
[TBL] [Abstract][Full Text] [Related]
16. Prediagnostic BMI trajectories in relation to pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Hoyt M; Song Y; Gao S; O'Palka J; Zhang J
Obesity (Silver Spring); 2022 Nov; 30(11):2275-2285. PubMed ID: 36156459
[TBL] [Abstract][Full Text] [Related]
17. Body mass index trajectories and prostate cancer risk: Results from the EPICAP study.
Lavalette C; Cordina Duverger E; Artaud F; Rébillard X; Lamy PJ; Trétarre B; Cénée S; Menegaux F
Cancer Med; 2020 Sep; 9(17):6421-6429. PubMed ID: 32639678
[TBL] [Abstract][Full Text] [Related]
18. Adolescent body mass index and risk of colon and rectal cancer in a cohort of 1.79 million Israeli men and women: A population-based study.
Levi Z; Kark JD; Katz LH; Twig G; Derazne E; Tzur D; Leibovici Weissman Y; Leiba A; Lipshiez I; Keinan Boker L; Afek A
Cancer; 2017 Oct; 123(20):4022-4030. PubMed ID: 28736986
[TBL] [Abstract][Full Text] [Related]
19. Obesity and prostate cancer screening, incidence, and mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Hurwitz LM; Dogbe N; Barry KH; Koutros S; Berndt SI
J Natl Cancer Inst; 2023 Dec; 115(12):1506-1514. PubMed ID: 37382561
[TBL] [Abstract][Full Text] [Related]
20. Postdiagnosis body mass index and risk of mortality in colorectal cancer survivors: a prospective study and meta-analysis.
Schlesinger S; Siegert S; Koch M; Walter J; Heits N; Hinz S; Jacobs G; Hampe J; Schafmayer C; Nöthlings U
Cancer Causes Control; 2014 Oct; 25(10):1407-18. PubMed ID: 25037235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
